You are currently viewing BIONOMOUS raises USD 2.7 million Series A funding in a round led by Nivalis Group

BIONOMOUS raises USD 2.7 million Series A funding in a round led by Nivalis Group

BIONOMOUS announces today it has raised a USD 2.7 million Series A funding round led by Nivalis Group, with participation from Cybernetix Ventures and Capital Risque Fribourg.

Since we founded Bionomous in 2019 it has been a challenging and exciting pathway to get where we are today. The closing of this Series A funding round is a huge milestone for our company. This investment allows us to scale the production of the EggSorter and prepare for global deployment

The investment round is led by Nivalis Group, a Swiss Holding based in Villaz-St-Pierre, with participation from Cybernetix Ventures, a leading robotics-focused US venture capital firm based in the Boston, and Capital Risque Fribourg, an early-stage investment company based in Fribourg. Fady Saad, Cybernetix Ventures Founder and Managing Partner, will join Bionomous board of directors.

Frank Bonnet, Bionomous CEO & co-founder explains:

“I am particularly proud of our team to have reached several milestones on time, which has been the key factor in convincing our current and new investors to finance the next phase of our venture. We are also very grateful to our customers who trusted us by adopting our products in their early phase”
Frank Bonnet
CEO & Co-founder Bionomous

Nivalis Group President, Christophe Fragnière about this new investment :

“We are delighted that Bionomous has successfully completed the first stage of industrialization. This important step and the dedication of the highly qualified Bionomous team has given us the confidence to strengthen our financial commitment. This recognition was also a positive sign to attract new investors.”
Christophe Fragnière
Nivalis Group President

For Cybernetix Ventures, the reasons to invest are clear:

“We have known Frank and the Bionomous team for some time and we have been impressed with their innovative product, solid traction in Europe and the US and their ability to quickly learn and scale. We are excited to be part of their journey”
Fady Saad
Cybernetix Ventures Managing Partner

We believe that this milestone would not have been possible without the amazing team that we have. Over the past year, we concentrated our efforts on optimizing the EggSorter based on the feedback received from early adopters. And, our new device obtained CE certification in December 2022 and is now ready to be deployed on the market.

We are starting now the commercialization phase of the EggSorter, with customers already in Europe, USA, and China, and this Series A funding is key to scale the production and to start expanding our sales globally. 

Read the official press release below.

Bionomous' first product: the EggSorter